New hope for autism? cannabis compound tested for Kids' irritability
NCT ID NCT03202303
Summary
This study is testing whether a non-psychoactive compound from the cannabis plant, called cannabidivarin (CBDV), can safely reduce irritability and repetitive behaviors in children with autism. It will involve 100 children and teens aged 5 to 18, comparing CBDV to a placebo over 12 weeks. The goal is to find a new treatment option with fewer side effects than current medications.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AUTISM SPECTRUM DISORDER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Montefiore Medical Center
RECRUITINGThe Bronx, New York, 10467, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
New York University (NYU) Langone
COMPLETEDNew York, New York, 10016, United States
Conditions
Explore the condition pages connected to this study.